Three tumors from each of the treatment groups (CAR-T, mock-T and saline-treated mice) were harvested on day 12 post-treatment and the CD45+ and CD45− cells from each tumor were column-sorted using magnetic beads. This evidence concerns the gene PTPRC and neoplasm.